These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7672682)

  • 21. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucolysis of the colonic mucus barrier by faecal proteinases: inhibition by interacting polyacrylate.
    Hutton DA; Pearson JP; Allen A; Foster SN
    Clin Sci (Lond); 1990 Mar; 78(3):265-71. PubMed ID: 2156646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
    Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
    J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lysozyme in Crohn's disease and ulcerative colitis.
    Helman CA; Novis BH; Bank S; Wormold L; Jacobs P
    S Afr Med J; 1977 Dec; 52(26):1042-4. PubMed ID: 609977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
    Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
    Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.
    Giaffer MH; Holdsworth CD; Duerden BI
    J Med Microbiol; 1991 Oct; 35(4):238-43. PubMed ID: 1941994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dietary fiber on fecal mucinase and beta-glucuronidase activity in rats.
    Shiau SY; Chang GW
    J Nutr; 1983 Jan; 113(1):138-44. PubMed ID: 6296339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal bile acid excretion in children with inflammatory bowel disease.
    Ejderhamn J; Rafter JJ; Strandvik B
    Gut; 1991 Nov; 32(11):1346-51. PubMed ID: 1752466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.
    el Yamani J; Mizon C; Capon C; Colombel JF; Fournet B; Cortot A; Mizon J
    Clin Sci (Lond); 1992 Oct; 83(4):409-15. PubMed ID: 1330402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activity of small intestine alkaline phosphatase in the feces in chronic intestinal diseases].
    Lehmann FG; Cramer P; Hillert U
    Z Gastroenterol; 1980 Apr; 18(4):208-15. PubMed ID: 7424074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mucinase activity of Helicobacter pylori: application of simplified mucinase test].
    Hashiguchi T
    Nihon Rinsho; 1993 Dec; 51(12):3166-9. PubMed ID: 8283626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal mucosal glycoprotein synthesis in inflammatory bowel diseases is not related to cigarette smoking.
    Ryder SD; Raouf AH; Parker N; Walker RJ; Rhodes JM
    Digestion; 1995; 56(5):370-6. PubMed ID: 8549879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid phase competitive luminescence immunoassay for immunoglobulin A in faeces: development and clinical validation.
    Schoof E; John MR; Arndt B; Gao P; Theuer D; Sieg A; Schmidt-Gayk H
    Clin Chim Acta; 1997 May; 261(1):1-17. PubMed ID: 9187500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease.
    Gosiewski T; Strus M; Fyderek K; Kowalska-Duplaga K; Wedrychowicz A; Jedynak-Wasowicz U; Sladek M; Pieczarkowski S; Adamski P; Heczko PB
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):20-7. PubMed ID: 21788912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum lysozyme in inflammatory bowel disease.
    Dobbins JW; Binder HJ; Spiro HM; Finch SC
    Gastroenterology; 1976 Mar; 70(3):469-71. PubMed ID: 1248707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease.
    Goodman MJ; Kent PW; Truelove SC
    Gut; 1977 Mar; 18(3):219-28. PubMed ID: 852752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease.
    Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
    Eur J Clin Invest; 2016 Oct; 46(10):825-32. PubMed ID: 27438629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.
    Nóbrega VG; Silva INN; Brito BS; Silva J; Silva MCMD; Santana GO
    Arq Gastroenterol; 2018; 55(3):290-295. PubMed ID: 30540094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis.
    Podolsky DK; Isselbacher KJ
    Gastroenterology; 1984 Nov; 87(5):991-8. PubMed ID: 6090262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.